AltPep
AltPep develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers. Its lead program focuses on identifying Alzheimer’s disease before symptoms appear and neutralizing the associated toxic oligomers. The organization aims to enable early screening and preventive intervention for these diseases.
Facts
- HQ
- Seattle, WA
- Sectors
- Biotechnology
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 32
- Registered name
- AltPep Corporation Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Innovation Journeys: Stories of Invention & Discovery at UW - Episode 2: AltPep
(https://comotion.uw.edu) Join UW Vice Provost for Innovation & CoMotion Director François Baneyx as he speaks with Dr. Valerie Daggett, Founder & CEO of UW spinoff AltPep (https://www.altpep.com/) and professor of bioengineering at the University of Washington, about her commercialization journey and how CoMotion supported it through funding, resources, programs and more.
People
-
Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO